C07D 231/50
Acylated on said nitrogen atom
C07D231/50 (Acylated on said nitrogen atom) appears on 19 US grants and 18 published applications in this corpus.
Search patents in C07D- Granted patents
- 19
- Published applications
- 18
- Assignees
- 16
- Inventors
- 78
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 2 |
| 2009 | 0 | 0 |
| 2010 | 3 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 2 |
| 2019 | 2 | 2 |
| 2020 | 2 | 2 |
| 2021 | 1 | 2 |
| 2022 | 1 | 0 |
| 2023 | 1 | 2 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pyrazolone formyl peptide 2 receptor agonists17 Mar 2026US 12,577,206 B2Bristol-Myers Squibb Company
- Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors2 Jul 2024US 12,024,523 B2AstraZeneca AB
- Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors4 Jul 2023US 11,691,978 B2AstraZeneca AB
- Compounds with antimicrobial activity25 Oct 2022US 11,479,529 B2The Chinese University of Hong Kong
- Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors11 May 2021US 11,001,589 B2AstraZeneca AB
- Paint thinner formulation11 Sep 2025US 2025/0282960 A1Hindustan Petroleum Corporation Limited
- Pyrazole derivatives useful as 5-lipoxygenase activating protein (flap) inhibitors26 Sep 2024US 2024/0317767 A1AstraZeneca AB
- Pyrazolone formyl peptide 2 receptor agonists10 Aug 2023US 2023/0250063 A1Bristol-Myers Squibb Company
- Pyrazole derivatives useful as 5-lipoxygenase activating protein (flap) inhibitors13 Jul 2023US 2023/0219967 A1AstraZeneca AB
- Pyrazole derivatives useful as 5-lipoxygenase activating protein (flap) inhibitors18 Nov 2021US 2021/0355127 A1AstraZeneca AB
Most cited
By later US patents
- N-(1-arylpyrazol-4L)sulfonamides and their use as parasiticides81US 7,803,832 B2Pfizer Inc. · 2010
- Herbicidal N-thienyl-chloroacetamides50US 4,666,502 ASandoz Ltd. · 1987
- Pyrazolone derivatives as MCP-1 antagonists20US 6,011,052 AWarner-Lambert Company · 2000
- Process for the preparation of carboxylic acid amides and peptides16US 4,331,592 AHoechst Aktiengesellschaft · 1982
- N-(1-arylpyrazol-4l) sulfonamides and their use as parasiticides7US 7,687,533 B2Pfizer Inc. · 2010